Wang Y, Pang X, Li R, Chen J, Wen C, Zhu H
Research (Wash D C). 2025; 8:0594.
PMID: 39872128
PMC: 11770199.
DOI: 10.34133/research.0594.
Larrea Murillo L, Sugden C, Ozsvari B, Moftakhar Z, Hassan G, Sotgia F
Cells. 2025; 13(24.
PMID: 39768151
PMC: 11674378.
DOI: 10.3390/cells13242059.
Baran Z, Cetinkaya M, Baran Y
Adv Exp Med Biol. 2024; 1474():149-177.
PMID: 39470980
DOI: 10.1007/5584_2024_824.
Antoon R, Overdevest N, Saleh A, Keating A
Oncogene. 2024; 43(49):3545-3555.
PMID: 39414984
PMC: 11602730.
DOI: 10.1038/s41388-024-03183-1.
Meybodi S, Moraddahande F, Dehghani Firoozabadi A
Heliyon. 2024; 10(9):e29858.
PMID: 38698968
PMC: 11064142.
DOI: 10.1016/j.heliyon.2024.e29858.
Mesenchymal Stem Cells Increase Drug Tolerance of A431 Cells Only in 3D Spheroids, Not in 2D Co-Cultures.
Vajda F, Szepesi A, Erdei Z, Szabo E, Varady G, Kiss D
Int J Mol Sci. 2024; 25(8).
PMID: 38674102
PMC: 11049889.
DOI: 10.3390/ijms25084515.
Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.
Wu C, Weng T, Li J, Wu K
Int J Mol Sci. 2024; 25(5).
PMID: 38473775
PMC: 10932140.
DOI: 10.3390/ijms25052527.
Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system.
Alhattab D, Isaioglou I, Alshehri S, Khan Z, Susapto H, Li Y
Biomater Res. 2023; 27(1):111.
PMID: 37932837
PMC: 10626721.
DOI: 10.1186/s40824-023-00457-9.
New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons.
Afkhami H, Mahmoudvand G, Fakouri A, Shadab A, Mahjoor M, Movahhed T
Front Cell Dev Biol. 2023; 11:1255697.
PMID: 37849741
PMC: 10577325.
DOI: 10.3389/fcell.2023.1255697.
The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential.
Slama Y, Ah-Pine F, Khettab M, Arcambal A, Begue M, Dutheil F
Int J Mol Sci. 2023; 24(17).
PMID: 37686315
PMC: 10488262.
DOI: 10.3390/ijms241713511.
Autocrine Factors Produced by Mesenchymal Stem Cells in Response to Cell-Cell Contact Inhibition Have Anti-Tumor Properties.
Chen J, Li R, Jiang J, Chen X
Cells. 2023; 12(17).
PMID: 37681882
PMC: 10486504.
DOI: 10.3390/cells12172150.
Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised,....
Jakobsen K, Fenger Carlander A, Gronhoj C, Todsen T, Melchiors J, Paaske N
Trials. 2023; 24(1):567.
PMID: 37658468
PMC: 10474624.
DOI: 10.1186/s13063-023-07594-5.
Multifunctional hybrid hydrogel for the prevention of post-surgery tumor recurrence.
Paresishvili T, Janelidze M, Kakabadze Z
Am J Cancer Res. 2023; 13(6):2504-2516.
PMID: 37424816
PMC: 10326567.
Case report: Stem cell-based suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene reduces tumor progression in multifocal glioblastoma.
Oraee-Yazdani S, Akhlaghpasand M, Rostami F, Golmohammadi M, Tavanaei R, Shokri G
Front Neurol. 2023; 14:1060180.
PMID: 37034076
PMC: 10075310.
DOI: 10.3389/fneur.2023.1060180.
Machine learning-based immune prognostic model and ceRNA network construction for lung adenocarcinoma.
He X, Su Y, Liu P, Chen C, Chen C, Guan H
J Cancer Res Clin Oncol. 2023; 149(10):7379-7392.
PMID: 36939925
DOI: 10.1007/s00432-023-04609-1.
Mechanisms of Long Non-Coding RNA in Breast Cancer.
Giuliani B, Tordonato C, Nicassio F
Int J Mol Sci. 2023; 24(5).
PMID: 36901971
PMC: 10002950.
DOI: 10.3390/ijms24054538.
The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment.
Li W, Liu Q, Shi J, Xu X, Xu J
Front Immunol. 2023; 14:1074863.
PMID: 36814921
PMC: 9940754.
DOI: 10.3389/fimmu.2023.1074863.
Effect of Co-culturing both placenta-derived mesenchymal stem cells and their condition medium in the cancer cell (HepG2) migration, damage through apoptosis and cell cycle arrest.
Dain Md Opo F, Moulay M, Alrefaei G, Alsubhi N, Alkarim S, Rahman M
Saudi J Biol Sci. 2022; 30(2):103519.
PMID: 36561333
PMC: 9763848.
DOI: 10.1016/j.sjbs.2022.103519.
Immune Checkpoint Inhibitors and Mesenchymal Stem/Stromal Cells Combination Therapy Might Offer a Promising Treatment Option for Cancer.
Lotfy A, Wang H
Stem Cell Rev Rep. 2022; 19(3):823-824.
PMID: 36454388
PMC: 10143520.
DOI: 10.1007/s12015-022-10474-1.
Human Mesenchymal Stem Cells Derived from the Placenta and Chorion Suppress the Proliferation while Enhancing the Migration of Human Breast Cancer Cells.
Sirithammajak S, Manochantr S, Tantrawatpan C, Tantikanlayaporn D, Kheolamai P
Stem Cells Int. 2022; 2022:4020845.
PMID: 36406002
PMC: 9674426.
DOI: 10.1155/2022/4020845.
